In focus · trending topic

Apogee Biotechnology

1 stories · following the connections

RedHill Biopharma Announces Peer-Reviewed Publication Demonstrating Therapeutic Potential of YELIVA™ in Cholangiocarcinoma Cancer

By Nasdaq OMXMar 10, 2016, 2:03 PM UTC